首页> 外文期刊>Current Pharmaceutical Biotechnology >Nanocarriers to Solid Tumors: Considerations on Tumor Penetration and Exposure of Tumor Cells to Therapeutic Agents
【24h】

Nanocarriers to Solid Tumors: Considerations on Tumor Penetration and Exposure of Tumor Cells to Therapeutic Agents

机译:固体肿瘤的纳米载体:肿瘤渗透和肿瘤细胞暴露于治疗药物的考虑。

获取原文
获取原文并翻译 | 示例
           

摘要

Solid tumors constitute the majority of diagnosed cancers. For effective killing, therapeutic agents should ideally be delivered uniformly and at lethal doses to all cancer cells comprising the tumors, while keeping normal organ tox-icities to a minimum. This requirement sets two of the major challenges in drug delivery to solid cancers: uniformity in delivery, and delivery of at least a minimum amount of therapeutics per cancer cell. Herein we review various approaches that aim to improve the penetration and content release of delivered therapeutic agents from nanocarriers of self-assembling nature. Biophysical characteristics of solid tumors are briefly discussed to motivate and rationalize the design of reported nanoparticle structures. This review does not aim to be exhaustive of the various designs and strategies, but to mostly give a flavor of the general current directions aiming to address these challenges.
机译:实体瘤构成了大多数已诊断的癌症。为了有效地杀死,理想地,应将治疗剂均匀地并且以致死剂量递送给构成肿瘤的所有癌细胞,同时保持正常器官的毒性最小。这项要求为实体癌的药物输送提出了两个主要挑战:输送的均匀性,以及每个癌细胞至少输送最少量的治疗剂。本文中,我们综述了旨在改善自组装性质的纳米载体中所递送治疗剂的渗透性和含量释放的各种方法。简要讨论了实体瘤的生物物理特征,以激发和合理化所报道的纳米颗粒结构的设计。这篇综述的目的不是要详尽地介绍各种设计和策略,而是要大致给出旨在应对这些挑战的当前总体方向。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号